H02 Superficial X-rays and grenz rays for benign dermatoses: from saviour to pariah over the course of the 20th century – the story of the remarkable rise and slow decline of an entire therapeutic modality and its potential for revival

Zinah Sharara,David J Gawkrodger

DOI: https://doi.org/10.1093/bjd/ljae090.350

IF: 11.113

2024-06-28

British Journal of Dermatology

Abstract:Abstract Dermatologists in the decade spanning the turn of the 19th century thought they were on to something with the discovery of X-rays by Wilhelm Röntgen at Würzburg in 1895. Effects on the skin were soon apparent from the earliest experiments, and dermatologists, keenly aware of Niels Finsen’s success using ultraviolet radiation for lupus vulgaris, quickly transmuted their interest to the new type of radiation. They were impressed with its benefits not only in lupus vulgaris but also in a wide range of disorders including important conditions such as acne, eczema, psoriasis, fungal infections and skin cancers. Major hospitals set up ‘electrical’ departments – the Middlesex Hospital had one from 1896 – and textbooks heavily featured the new modality. Malcolm Morris’s 1911 Diseases of the Skin lists X-ray treatment for no fewer than 38 conditions. Grenz rays, with wavelengths nearer the ultraviolet and not so penetrative as X-rays, found similar applications. In the absence of an overabundance of effective topical therapies, and despite the growing realization that overdosage was a potential hazard, superficial X-rays represented a major limb of the dermatologist’s armamentarium through the interwar years and beyond. Fifty-five per cent of office dermatologists in the USA of 1975 had their own X-ray machine. Most British skin clinics had machines and dedicated radiographers to boot. The decline started with the topical corticosteroid revolution of the 1960s and accelerated after that, such that by the 1980s, with the removal of X-ray machines from dermatology departments, radiologists were disinclined to permit the use of superficial X-rays for benign dermatoses. Some centres pressed on with their use for a while in hard-to-treat eczema or psoriasis of the hands or feet, but the current guidelines no longer support this, describing the treatment as ‘obsolete’. The use of more penetrating radiation has been maintained for certain skin cancer indications. Considering that many biologics with serious and not uncommon side-effects are now prescribed at quite a low severity bar, it is tempting to think that the toxicity of judiciously applied superficial X-rays might be of a similar or even lesser order. Perhaps this previously indispensable modality is due a revival?

dermatology